Isofol’s Drug Candidate Arfolitixorin Receives Clinical Patent Approval in the United States PRNewswire
GOTHENBURG, Sweden, May 21, 2019 /PRNewswire/ — Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a clinical …